Development of 11&bgr; -HSD1 Inhibitors for the Treatment of Type 2 Diabetes

E-ISSN： 1875-5607|8|7|702-710

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.7, 2008-06, pp. : 702-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

By Morgan Stuart A Tomlinson Jeremy W

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1067-1076

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes

Current Pharmaceutical Design, Vol. 10, Iss. 10, 2004-04 ,pp. : 1105-1137

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite

11&bgr;-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

Current Medicinal Chemistry, Vol. 17, Iss. 5, 2010-02 ,pp. : 412-422

Bentham Science Publishers

Access to resources Recommend Favorite

Substituted 1,2,4-oxodiazoles as Potent Inhibitors of Human 11bgr; - hydroxysteroid Dehydrogenase Type 1 (11bgr;-HSD1): Virtual Screening and Docking Results

Letters in Drug Design & Discovery, Vol. 13, Iss. 3, 2016-03 ,pp. : 226-233

Bentham Science Publishers

Access to resources Recommend Favorite